Literature DB >> 12005438

Downstream regulator TANK binds to the CD40 recognition site on TRAF3.

Chenglong Li1, Chao-Zhou Ni, Marnie L Havert, Edelmira Cabezas, Jeannie He, Donald Kaiser, John C Reed, Arnold C Satterthwait, Genhong Cheng, Kathryn R Ely.   

Abstract

TRAFs (tumor necrosis factor receptor [TNFR]-associated factors) bind to the cytoplasmic portion of liganded TNFRs and stimulate activation of NF-kappaB or JNK pathways. A modulator of TRAF signaling, TANK, serves as either an enhancer or an inhibitor of TRAF-mediated signaling pathways. The crystal structure of a region of TANK bound to TRAF3 has been determined and compared to a similar CD40/TRAF3 complex. TANK and CD40 bind to the same crevice on TRAF3. The recognition motif PxQxT is presented in a boomerang-like structure in TANK that is markedly different from the hairpin loop that forms in CD40 upon binding to TRAF3. Critical TANK contact residues were confirmed by mutagenesis to be required for binding to TRAF3 or TRAF2. Binding affinity, measured by isothermal titration calorimetry and competition assays, demonstrated that TANK competes with CD40 for the TRAF binding site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005438     DOI: 10.1016/s0969-2126(02)00733-5

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  19 in total

1.  Comparison of the peptide binding preferences of three closely related TRAF paralogs: TRAF2, TRAF3, and TRAF5.

Authors:  Glenna Wink Foight; Amy E Keating
Journal:  Protein Sci       Date:  2016-02-03       Impact factor: 6.725

2.  Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.

Authors:  Supriya K Saha; Eric M Pietras; Jeannie Q He; Jason R Kang; Su-Yang Liu; Gagik Oganesyan; Arash Shahangian; Brian Zarnegar; Travis L Shiba; Yao Wang; Genhong Cheng
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

Review 3.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Adaptive evolution in two large families of ubiquitin-ligase adapters in nematodes and plants.

Authors:  James H Thomas
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

5.  Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.

Authors:  Zhubing Shi; Zhen Zhang; Zhenzhen Zhang; Yanyan Wang; Chuanchuan Li; Xin Wang; Feng He; Lina Sun; Shi Jiao; Weiyang Shi; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

6.  Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5.

Authors:  Peng Zhang; Anna Reichardt; Huanhuan Liang; Roghiyh Aliyari; David Cheng; Yaya Wang; Feng Xu; Genhong Cheng; Yingfang Liu
Journal:  Sci Signal       Date:  2012-11-13       Impact factor: 8.192

7.  TRAF family member-associated NF-kappa B activator (TANK) expression increases in injured sensory neurons and is transcriptionally regulated by Sox11.

Authors:  K M Salerno; X Jing; C M Diges; B M Davis; K M Albers
Journal:  Neuroscience       Date:  2012-11-29       Impact factor: 3.590

8.  Molecular basis for unique specificity of human TRAF4 for platelets GPIbβ and GPVI.

Authors:  Chang Min Kim; Young-Jin Son; Sunghwan Kim; Seo Yun Kim; Hyun Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-10       Impact factor: 11.205

Review 9.  Structural feature of TRAFs, their related human diseases and therapeutic intervention.

Authors:  Hyun Ho Park
Journal:  Arch Pharm Res       Date:  2021-05-10       Impact factor: 4.946

10.  The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.

Authors:  Peyman Nakhaei; Thibault Mesplede; Mayra Solis; Qiang Sun; Tiejun Zhao; Long Yang; Tsung-Hsien Chuang; Carl F Ware; Rongtuan Lin; John Hiscott
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.